[1] |
GBD 2015 Risk Factors Collaborators. Global,regional,and national comparative risk assessment of 79 behavioural,environmental and occupational,and metabolic risks or clusters of risks,1990-2015:a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet,2016,388(10053):1659-1724.
|
[2] |
中国心血管病报告编写组. 《中国心血管病报告2016》概要[J]. 中国循环杂志,2017,32(6):521-530.
|
[3] |
GENSINI G G.A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol,1983,51(3):606.
|
[4] |
吴卫云,邬升超,颜红梅,等. PCI手术患者血清TSH水平与心血管疾病严重程度的相关性研究[J]. 检验医学,2015,30(5):489-494.
|
[5] |
CATAPANO A L,GRAHAM I,DE BACKER G,et al.2016 ESC/EAS guidelines for the management of dyslipidaemias[J]. Eur Heart J,2016,37(39):2999-3058.
|
[6] |
李运丽,王岚峰. 脂蛋白(a)与心血管疾病的研究进展[J]. 中国循证心血管医学杂志,2017,9(6):766-768.
|
[7] |
MALAGUARNERA M,VACANTE M,RUSSO C,et al.Lipoprotein(a) in cardiovascular diseases[J]. Biomed Res Int,2013,2013:650989.
|
[8] |
CAI A,LI L,ZHANG Y,et al.Lipoprotein(a):a promising marker for residual cardiovascular risk assessment[J]. Dis Markers,2013,35(5):551-559.
|
[9] |
TSIMIKAS S.A test in context:lipoprotein(a):diagnosis,prognosis,controversies,and emerging therapies[J]. J Am Coll Cardiol,2017,69(6):692-711.
|
[10] |
SUWA S,OGITA M,MIYAUCHI K,et al.Impact of lipoprotein(a) on long-term outcomes in patients with coronary artery disease treated with statin after a first percutaneous coronary intervention[J]. J Atheroscler Thromb,2017,24(11):1125-1131.
|
[11] |
HALTER J B,MUSI N,MCFARLAND HORNE F,et al.Diabetes and cardiovascular disease in older adults:current status and future directions[J]. Diabetes,2014,63(8):2578-2589.
|
[12] |
HU D Y,PAN C Y,YU J M,et al.The relationship between coronary artery disease and abnormal glucose regulation in China:the China Heart Survey[J]. Eur Heart J,2006,27(21):2573-2579.
|
[13] |
NATALI A,BALDI S,BONNET F,et al.Plasma HDL-cholesterol and triglycerides,but not LDL-cholesterol,are associated with insulin secretion in non-diabetic subjects[J]. Metabolism,2017,69:33-42.
|
[14] |
马茜,张惠英. 血糖对冠状动脉狭窄程度及斑块性质的影响[J]. 华北理工大学学报(医学版),2017,19(3):204-207.
|
[15] |
陈炎,庞文晶,周立波. m-AST与AST比值在冠心病、肝脏疾病患者病程中的变化及临床意义[J]. 宁夏医科大学学报,2013,35(11):1269-1271.
|
[16] |
GAO M,CHENG Y,ZHENG Y,et al.Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. BMC Cardiovasc Disord,2017,17(1):43.
|
[17] |
SHEN J,ZHANG J,WEN J,et al.Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease[J]. Int J Clin Exp Med,2015,8(3):4399-4404.
|
[18] |
许浩生. 心脏病患者血清天门冬氨酸氨基转移酶及其同工酶检测的临床意义[J]. 中国实用医药,2016,11(4):21-22.
|
[19] |
ADIBI P,SADEGHI M,MAHSA M,et al.Prediction of coronary atherosclerotic disease with liver transaminase level[J]. Liver Int,2007,27(7):895-900.
|